Please assess the completion status of the following clinical trial:

Trial Title: Remimazolam vs Desflurane for General Anesthesia for Ablation of Arrhythmia

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* =or \> 20 years~* Admission for General anesthesia for RFCA or cryoablation procedure~Exclusion Criteria:~* No severe adverse effect history or hypersensitivity of benzodiazepines or its additives~* Acute alcoholic intoxication state~* Coma or shock state due to other condition than heart problem.~* Acute narrow-angle glaucoma

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: 105 Years
- Healthy Volunteers: f

Study Arms:
- Remimazolam (Type: EXPERIMENTAL): General anesthesia with remimazolam-remifentanil TIVA.
- Desflurane (Type: NO_INTERVENTION): General anesthesia with maintaining with desflurane (induction:PPF, remifentanil CIV)

Based on this trial design, predict the completion outcome and termination type (if applicable).